$11.04
0[0.00%]
At close: Jun 14
$11.04
0[0.00%]
After Hours: 4:00PM EDT
Gyre Therapeutics
(NASDAQ:GYRE)Gyre Therapeutics (GYRE) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGyre Therapeutics (NASDAQ:GYRE) Stock Quotes, Forecast and News Summary
Gyre Therapeutics Stock (NASDAQ: GYRE) stock price, news, charts, stock research, profile.
| Open | $11.320 |
| Close | $11.040 |
| Volume / Avg. | 19.201K / 63.733K |
| Day Range | 10.900 - 11.360 |
| 52 Wk Range | 5.880 - 30.400 |
| Market Cap | $944.032M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | 3.17% |
| Days to Cover | 2.7 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gyre Therapeutics (GYRE) stock?
You can purchase shares of Gyre Therapeutics (NASDAQ:GYRE) through any online brokerage.
Who are Gyre Therapeutics (GYRE) competitors?
Other companies in Gyre Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA) and Cogent Biosciences (NASDAQ:COGT).
What is the target price for Gyre Therapeutics (GYRE) stock?
There is no analysis for Gyre Therapeutics
What is the forecast for Gyre Therapeutics (GYRE) stock?
There is no analysis for Gyre Therapeutics to provide a consensus price target.
Current stock price for Gyre Therapeutics (GYRE)?
The stock price for Gyre Therapeutics (NASDAQ: GYRE) is $11.04 last updated June 14, 2024 at 4:00 PM EDT.
Does Gyre Therapeutics (GYRE) pay a dividend
There are no upcoming dividends for Gyre Therapeutics.
When is Gyre Therapeutics (NASDAQ:GYRE) reporting earnings?
Gyre Therapeutics’s Q2 earnings are confirmed for Wednesday, August 21, 2024.
Is Gyre Therapeutics (GYRE) going to split?
There is no upcoming split for Gyre Therapeutics.
What sector and industry does Gyre Therapeutics (GYRE) operate in?
Gyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.